Hematologic malignancies in temozolomide-treated metastatic pancreatic neuroendocrine tumours

被引：0
|
作者：
Balmaceda, N. [1 ]
Mouw, T. [2 ]
Abhyankar, S. [3 ]
Male, H. [3 ]
Woodroof, J. [4 ]
Williamson, S. [5 ]
Baranda, J. [5 ]
机构：
[1] Univ Kansas, Med Ctr, Internal Med, Kansas City, MO USA
[2] Univ Kansas, Med Ctr, Gen Surg, Kansas City, MO USA
[3] Univ Kansas, Med Ctr, Hematol, Kansas City, MO USA
[4] Univ Kansas, Med Ctr, Pathol, Kansas City, MO USA
[5] Univ Kansas, Med Ctr, Med Oncol, Kansas City, MO USA
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1399P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sunitinib in pancreatic neuroendocrine tumours
    Lahner, H.
    Rinke, A.
    Poeppel, T. D.
    Fuehrer, D.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (03)
  • [22] Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
    De Divitiis, C.
    von Arx, C.
    Grimaldi, A. M.
    Cicala, D.
    Tatangelo, F.
    Arcella, A.
    Romano, G. M.
    Simeone, E.
    Iaffaioli, R. V.
    Ascierto, P. A.
    Tafuto, S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [23] MRI of pancreatic neuroendocrine tumours
    Owen, NJ
    Sohaib, SAA
    Peppercorn, PD
    Monson, JP
    Grossman, AB
    Besser, GM
    Reznek, RH
    BRITISH JOURNAL OF RADIOLOGY, 2001, 74 (886): : 968 - 973
  • [24] ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis
    Weatherbee, Jessica L.
    Kraus, Jean-Louis
    Ross, Alonzo H.
    ONCOTARGET, 2016, 7 (28) : 43820 - 43834
  • [25] METASTATIC PANCREATIC NEUROENDOCRINE TUMOURS: DOES AGGRESSIVE SURGICAL INTERVENTION IMPROVE OUTCOME?
    White, M. J.
    Edwards, L. M.
    Cawich, S. O.
    Frola, C.
    Abu Hilial, M.
    Pearce, N. W.
    GUT, 2012, 61 : A56 - A56
  • [26] FINE NEEDLE ASPIRATION OF METASTATIC AND HEMATOLOGIC MALIGNANCIES CLINICALLY MIMICKING PANCREATIC-CARCINOMA
    BENNING, TL
    SILVERMAN, JF
    BERNS, LA
    GEISINGER, KR
    ACTA CYTOLOGICA, 1992, 36 (04) : 471 - 476
  • [27] PANCREATIC NEUROENDOCRINE TUMOURS - A RARE PANCREATIC TUMOUR
    Chan, David L.
    Pavlakis, Nick
    Roach, Paul
    Bailey, Dale
    Arena, Jennifer
    Segelov, Eva
    CANCER FORUM, 2016, 40 (01) : 34 - 39
  • [28] Capecitabine and temozolomide (CAPTEM) for intermediate to high grade metastatic neuroendocrine tumours (NET): A single centre experience
    Sahu, Arvind
    Jefford, Michael
    Lai-Kwon, Julia
    Hicks, Rod
    Thai, Alesha
    Michael, Michael
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 102 - 102
  • [29] The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors
    Ramirez, Robert A.
    Beyer, David T.
    Chauhan, Aman
    Boudreaux, J. Philip
    Wang, Yi-Zarn
    Woltering, Eugene A.
    ONCOLOGIST, 2016, 21 (06): : 671 - 675
  • [30] Response to Capecitabine and Temozolomide in an Adolescent Female With Metastatic, Non-functional Pancreatic Neuroendocrine Tumor
    Gilbert, Leslie
    Bobbey, Adam
    Snyder, Kristen
    PANCREAS, 2015, 44 (02) : 353 - 353
12345